Logo NeoGenomica

Accompanied genetic evaluation

Longevo Premium: genetic testing with follow-up.

The same genetic analysis as Longevo, with two consultations — before and after testing — and one clinical review of the data each year for four years.

Young couple planning healthcare
The result is discussed in light of history, habits and care objectives.
Accepted samples
Peripheral blood, Buccal swab (preferred), Extracted DNA
Turnaround time and when it starts
20 calendar days, after acceptance of the sample
Medical order
Not required. View requirements and limitations.

Longitudinal monitoring

The examination begins before sample collection.

The pre-test consultation defines the relevant questions. After the analysis, the post-test consultation organizes what the result means for you. Over the next four years, an annual clinical reassessment revisits the data in light of new evidence and your health monitoring.

01 · Initial assessment

History, habits and goals

The doctor reviews personal and family history, lifestyle, previous tests and questions about the test.

02 · Longevo

The same genetic content

The sample is collected with a mouth swab and goes through the same genetic analysis, specialized curation and preventive scope offered by Longevo.

03 · Return and continuity

Result in context, year after year

The post-test consultation explains findings, limits and next steps. The data then receives annual clinical reassessment for four consecutive years.

Same content as Longevo

More than 100 conditions evaluated.

Longevo Premium fully maintains the genetic analysis of Longevo: 155 genes, selected polygenic scores and pharmacogenomics. The difference is in the clinical journey before, after and over the following four years.

01

Hereditary cancer

Breast and ovarian, colorectal, prostate, endocrine tumors, melanoma and other predisposing syndromes.

02

Cardiovascular health

Cardiomyopathies, arrhythmias, aortic diseases, hereditary cholesterol and polygenic risk of heart attack.

03

Neurology and metabolism

Neurodegenerative, neuromuscular, metabolic, endocrine conditions and changes in iron metabolism.

04

Pharmacogenomics

Information on the response and metabolism of selected medications, including in mental health.

Dr. João Bosco de Oliveira Filho at a scientific event

Medical follow-up

Clinical experience to interpret what matters.

Monitoring is carried out by Dr. João Bosco de Oliveira Filho, founder of NeoGenomica and a doctor with more than 20 years of experience in clinical genetics.

Before the test
Defining objectives and collecting clinical information.
After the report
Post-test consultation and annual clinical re-evaluation of data for four consecutive years.

Follow-up after your results

Infinity VUS

All NeoGenomica tests include Infinity VUS to follow reported variants of uncertain significance. When a relevant reclassification is confirmed after specialist review, the doctor is notified and the report may be updated.

Understand results and Infinity VUS

Accompanied journey

From assessment to monitoring.

An organized journey to link genetic data, history and prevention.

  1. 01

    Scheduling

    The team confirms the service and guides the preparation for the evaluation.

  2. 02

    Pre-test consultation

    The doctor reviews the history, objectives and questions before sample collection.

  3. 03

    Sample collection

    The buccal swab is collected and sent to the laboratory with traceability.

  4. 04

    Genetic analysis

    The DNA goes through the same genetic content and the same curation as Longevo.

  5. 05

    Return and follow-up

    The report is contextualized in the post-test consultation and the data receives annual clinical reevaluation for four consecutive years.

Clinical feedback

Clarity about findings and limits.

The report brings together the results by clinical area. At the return visit, each finding is related to the history and follow-up recommendations.

  • Summary of main findings.
  • Analysis by health category.
  • Points for prevention, tracking and referral.
Anonymized excerpt from the preventive genetic report that is part of Longevo Premium
Demonstrative and anonymized example of the preventive genetic report included in Longevo Premium.

Frequently asked questions

Before scheduling.

What is the difference between Longevo and Longevo Premium?+

The genetic content is the same. Longevo Premium adds pre-test consultation, post-test consultation and annual clinical re-evaluation of data for four consecutive years.

How do four-year revaluations work?+

Once a year for four consecutive years, the data undergo clinical review to consider relevant new evidence and updated health information. Reviews do not include new sequencing or a new medical consultation. They do not replace routine tests or ongoing care.

Do I need a medical request?+

No. The initial assessment itself organizes the indication, objectives and information necessary for the test.

How are consultations carried out?+

The team informs you of the modality and availability when scheduling. The first consultation takes place before sample collection and the return after the report is released.

Does the result automatically change medications or screenings?+

No. The report generates information for clinical discussion. Changes in treatment, medication or screening depend on individual assessment.

Is the test covered by health insurance?+

The service is private. The team can provide documentation to request reimbursement when the plan contract allows.

When will the result be ready?+

20 calendar days, after acceptance of the sample . The follow-up consultation is scheduled after the report is released.

Clinical follow-up

Start with the conversation, not the report.

Schedule a pre-test consultation and understand how Longevo Premium can track your data for four consecutive years.

Test information

Technical details for Longevo Premium

Method, scope, requirements and limitations

The same content as Longevo, with pre- and post-test consultations and annual clinical reassessment for four years.

Applications
Hereditary cancer, Personalized prevention, Cardiovascular risk, Pharmacogenomics
Accepted samples
Peripheral blood, Buccal swab (preferred), Extracted DNA
Estimated turnaround time
20 calendar days, after acceptance of the sample
Methodology
Genetic content and curation of Longevo, integrated with longitudinal medical monitoring.
Analytical scope
155 genes, selected polygenic scores and pharmacogenomics; pre- and post-examination consultations and an annual clinical reassessment for four years.
Medical order
Not mandatory

Requirements

Does not require a medical request; the initial assessment organizes indication, objectives and necessary information. Home sample collection uses a mouth swab.

Limitations

Findings and scores must be interpreted in conjunction with history, habits, tests and goals of care.

Additional information

The genetic content is the same as Longevo; the difference is the clinical journey. The reassessment is annual for four consecutive years.